Atlas Trials

Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR

Clinical trial NCT00240682 · COMPLETED

Trial details

NCT number
NCT00240682
Sponsor
Centre Hospitalier of Chartres
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Skin DiseasesCarcinoma, Squamous Cell
Start date
2005-10-01
Primary completion
2009-04-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.